Related references
Note: Only part of the references are listed.Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas
Mina M. Gerges et al.
JOURNAL OF NEUROSURGERY (2021)
Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma
Wen Lyu et al.
GLAND SURGERY (2021)
Ki-67 labeling index and Knosp classification of pituitary adenomas
Li Yuhan et al.
BRITISH JOURNAL OF NEUROSURGERY (2021)
A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study
Xiangming Cai et al.
FRONTIERS IN ONCOLOGY (2021)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Jacqueline Trouillas et al.
CANCERS (2020)
Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study
Alberto Conficoni et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
World Health Ozganization 2017 Classification of Pituitary Tumors
M. Beatriz S. Lopes
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age
Geraldine Trott et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2019)
The Treatment of Refractory Pituitary Adenomas
Congxin Dai et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning
Lorenzo Ugga et al.
NEURORADIOLOGY (2019)
Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors
Chhanda Das et al.
JOURNAL OF LABORATORY PHYSICIANS (2019)
Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran
Shahrzad Mohseni et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma
Brigita Glebauskiene et al.
BIOMED RESEARCH INTERNATIONAL (2018)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
The Likelihood of Remnant Nonfunctioning Pituitary Adenomas Shrinking Is Associated with the Lesion's Blood Supply Pattern
Miiko Ito et al.
WORLD NEUROSURGERY (2017)
Ki67 Labeling Correlated With Invasion But Not With Recurrence
Alireza Sadeghipour et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects
Moises Mercado et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2017)
A Prognostic Clinicopathologic Classification of Pituitary Endocrine Tumors
Gerald Raverot et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2015)
Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth
Andrej Steno et al.
ACTA NEUROCHIRURGICA (2014)
Endocan, a new invasion and angiogenesis marker of pituitary adenomas
Fumihiro Matano et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Epidemiology and etiopathogenesis of pituitary adenomas
Elena D. Aflorei et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Antiangiogenic therapy for high-grade glioma
Mustafa Khasraw et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index
Y Tanaka et al.
JOURNAL OF NEUROSURGERY (2003)
Share Paper
